These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8440049)
1. Cutaneous malignancy related to cyclosporin A therapy. Green C; Hawk JL Clin Exp Dermatol; 1993 Jan; 18(1):30-1. PubMed ID: 8440049 [No Abstract] [Full Text] [Related]
2. Cancer induction by immunosuppression in psoriasis after heavy PUVA treatment. Molin L; Larkö O Acta Derm Venereol; 1997 Sep; 77(5):402. PubMed ID: 9298142 [No Abstract] [Full Text] [Related]
3. [Puva therapy and carcinogenesis]. Thomas P; Pannequin C Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842 [No Abstract] [Full Text] [Related]
4. Does photochemotherapy increase the risk of skin cancer? Lancet; 1979 May; 1(8124):1011-2. PubMed ID: 86724 [No Abstract] [Full Text] [Related]
9. ["Superficial spreading melanoma" within a psoriasis focus as a delayed sequela following arsenic therapy for psoriasis]. Grobe JW Berufsdermatosen; 1976; 24(6):167-9. PubMed ID: 1016213 [TBL] [Abstract][Full Text] [Related]
11. [Multiple superficial skin basalioma in a patient with psoriasis]. El'kin VD; Osnovina NG Vestn Dermatol Venerol; 1980 Apr; (4):37-8. PubMed ID: 7395348 [No Abstract] [Full Text] [Related]
12. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. Stern RS; Liebman EJ; Väkevä L J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734 [TBL] [Abstract][Full Text] [Related]
13. Early and explosive development of nodular basal cell carcinoma and multiple keratoacanthomas in psoriasis patients treated with cyclosporine. Lain EL; Markus RF J Drugs Dermatol; 2004; 3(6):680-2. PubMed ID: 15624753 [TBL] [Abstract][Full Text] [Related]
14. Sebaceous hyperplasia and basal cell carcinoma in a renal transplant patient receiving cyclosporine. Pakula A; Garden J J Am Acad Dermatol; 1992 Jan; 26(1):139-40. PubMed ID: 1732329 [No Abstract] [Full Text] [Related]
15. Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic. Torchia D; Massi D; Caproni M; Fabbri P Int J Dermatol; 2008 Jun; 47(6):592-3. PubMed ID: 18477152 [No Abstract] [Full Text] [Related]
16. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Stern RS; Laird N Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017 [TBL] [Abstract][Full Text] [Related]
17. Use of methotrexate and risk of skin cancer: a nationwide case-control study. Polesie S; Gillstedt M; Schmidt SAJ; Egeberg A; Pottegård A; Kristensen K Br J Cancer; 2023 Mar; 128(7):1311-1319. PubMed ID: 36739322 [TBL] [Abstract][Full Text] [Related]
18. Statins in dermatology: is nonmelanoma skin cancer the dark side of the moon? Mascitelli L; Goldstein MR Int J Dermatol; 2013 Jul; 52(7):899-900. PubMed ID: 22512761 [No Abstract] [Full Text] [Related]
19. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance. van de Kerkhof PC; de Rooij MJ Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750 [TBL] [Abstract][Full Text] [Related]
20. On methotrexate treatment of psoriasis. Model of a cytostatics treatment. Schnitzer A Dermatologica; 1972; 145(2):115-20. PubMed ID: 4542005 [No Abstract] [Full Text] [Related] [Next] [New Search]